3.0
11 Aug 2013
Current employee, more than 8 years
Recommend
CEO approval
Business outlook
Pros
Lots of smart, hardworking people Excellent benefits Excellent values at the institutional level
Cons
Soft-money side enterprise is merciless and mercenary, cares way more about bottom like than scholarship or students. Current lack of Federal funding for science makes soft-money medical research a house of cards. Its collapsing and leadership is oblivious.